AKU wins Rs14.5mn grant to develop new, targeted stem cell treatments for blood cancer
AKDN / Matteo Piazza
This page is also available inArticle Author: AKU wins Rs14.5mn grant to develop new, targeted stem cell treatments for blood cancer
Media Source: The News (Pakistan)
Date: 20 January 2021
The Aga Khan University (AKU)’s Centre for Regenerative Medicine and Stem Cell Research (CRM) has won a Rs14.5 million grant to develop new, targeted therapies for a common form of blood cancer in adults. AKU researchers are looking to develop a more effective treatment by engineering stem cells to deliver a protein with the
The Aga Khan University (AKU)’s Centre for Regenerative Medicine and Stem Cell Research (CRM) has won a Rs14.5 million grant to develop new, targeted therapies for a common form of blood cancer in adults. AKU researchers are looking to develop a more effective treatment by engineering stem cells to deliver a protein with therapeutic properties. The grant was awarded by the Higher Education Commission of Pakistan’s flagship National Research Programme for Universities that seeks to support high-level and promising scientific research projects that demonstrate strategic relevance and impact to local industry and society.